Atossa Therapeutics (ATOS) Return on Equity [ROE] (2012 - 2026)
Atossa Therapeutics' Return on Equity [ROE] came in at -131.58% for Q2 2026, down 84.89 percentage points from -46.69% a year earlier and down 23.79 percentage points from the prior quarter.
Powered by 
Analysis
Atossa Therapeutics (ATOS) Return on Equity [ROE] (2012 - 2026) Analysis & Trends
For FY2025, Atossa Therapeutics' Return on Equity [ROE] was -62.74%, down 31.35 percentage points from FY2024.
- Return on Equity [ROE] has declined in each of the last three years, though with a five-year change of +25.68 percentage points (FY2020 to FY2025).
- Going back by year, Return on Equity [ROE] was -31.39% in FY2024 (-2.59 pp), -28.80% in FY2023 (-7.75 pp), -21.05% in FY2022 (+3.88 pp) and -24.93% in FY2021 (+63.49 pp).
- The Q2 2026 figure represents the lowest quarterly Return on Equity [ROE] since Q3 2020.
- Year-over-year, Return on Equity [ROE] has declined for 17 consecutive quarters, with an average year-over-year change of -30.94 percentage points over the last eight quarters.
- The fastest year-over-year change in Return on Equity [ROE] over five years came in Q3 2021 (a gain of 125.80 percentage points), and the weakest in Q2 2026 (a drop of 84.89 percentage points).
- Business Quant data shows ATOS's Return on Equity [ROE] at -107.79% (Q1 2026), -78.01% (Q4 2025) and -56.16% (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 25.32% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 7.21% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 84.40% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 21.39% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 83.75% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -18.38% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 4.97% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 22.24% |
| 10 | Atossa Therapeutics | 19.46 Mn | 19.46 Mn | - | -131.58% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -131.58% |
| Mar 31, 2026 | -107.79% |
| Dec 31, 2025 | -78.01% |
| Sep 30, 2025 | -56.16% |
| Jun 30, 2025 | -46.69% |
| Mar 31, 2025 | -38.51% |
| Dec 31, 2024 | -35.14% |
| Sep 30, 2024 | -34.99% |
| Jun 30, 2024 | -31.23% |
| Mar 31, 2024 | -33.59% |
| Dec 31, 2023 | -31.80% |
| Sep 30, 2023 | -29.37% |
| Jun 30, 2023 | -28.99% |
| Mar 31, 2023 | -24.61% |
| Dec 31, 2022 | -22.30% |
| Sep 30, 2022 | -19.13% |
| Jun 30, 2022 | -16.19% |
| Mar 31, 2022 | -15.99% |
| Dec 31, 2021 | -14.75% |
| Sep 30, 2021 | -16.30% |
API Access
Atossa Therapeutics Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=ATOS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "ATOS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=ATOS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();